These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

90 related articles for article (PubMed ID: 24695038)

  • 1. First study of angiotensin converting enzyme in cystic fibrosis Tunisian patients.
    Sahli C; Fredj SH; Siala H; Bibi A; Messaoud T
    Clin Chem Lab Med; 2014 Sep; 52(9):e211-5. PubMed ID: 24695038
    [No Abstract]   [Full Text] [Related]  

  • 2. Angiotensin-converting enzyme insertion/deletion gene polymorphism in cystic fibrosis patients.
    Oueslati S; Hadj Fredj S; Siala H; Bibi A; Aloulou H; Boughamoura L; Boussetta K; Barsaoui SB; Messaoud T
    J Genet; 2016 Mar; 95(1):193-6. PubMed ID: 27019450
    [No Abstract]   [Full Text] [Related]  

  • 3. Cystic fibrosis transmembrane conductance regulator mutation spectrum in patients with cystic fibrosis in Tunisia.
    Fredj SH; Messaoud T; Templin C; des Georges M; Fattoum S; Claustres M
    Genet Test Mol Biomarkers; 2009 Oct; 13(5):577-81. PubMed ID: 19715466
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Identification of a cystic fibrosis mutation W19X in Tunisia.
    Boudaya M; Fredj SH; Siala H; Bibi A; Messaoud T
    Ann Biol Clin (Paris); 2013; 71(2):223-6. PubMed ID: 23587593
    [TBL] [Abstract][Full Text] [Related]  

  • 5. New frameshift CF mutation 3729delAinsTCT in a Tunisian cystic fibrosis patient.
    Hadj Fredj S; Boudaya M; Oueslati S; Sahnoun S; Sahli C; Siala H; Boussetta K; Bibi A; Messaoud T
    J Genet; 2013 Apr; 92(1):81-3. PubMed ID: 23640408
    [No Abstract]   [Full Text] [Related]  

  • 6. Association of MP6d9 Polymorphism with Clinical Variability in Cystic Fibrosis Patients.
    Sahli C; Hadj-Fredj S; Dabboubi R; Bousseta K; Mehrzi A; Messaoud T
    Clin Lab; 2016 Nov; 62(11):2139-2143. PubMed ID: 28164663
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Cystic Fibrosis mutation W19X in Tunisia: Second case identified.
    Lamouchi MT
    Tunis Med; 2020 May; 98(5):420-422. PubMed ID: 32548846
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Newborn screening for cystic fibrosis.
    Wallace J; Stein Q
    S D Med; 2006 Oct; 59(10):429-31. PubMed ID: 17124920
    [No Abstract]   [Full Text] [Related]  

  • 9. First study of the F508del mutation in Malaysian children diagnosed with cystic fibrosis.
    Nathan AM; Thong MK; deBruyne J; Ariffin H
    J Paediatr Child Health; 2011 Aug; 47(8):573-5. PubMed ID: 21843195
    [No Abstract]   [Full Text] [Related]  

  • 10. Sweat chloride concentration in cystic fibrosis patients with cystic fibrosis trans-membrane conductance regulator I1234V mutation.
    Abdul-Wahab A; Janahi IA; Abdel-Rahman MO
    Saudi Med J; 2009 Aug; 30(8):1101-2. PubMed ID: 19668897
    [No Abstract]   [Full Text] [Related]  

  • 11. [Challenges of genetic diseases. About a genetic disease: cystic fibrosis].
    Labrune P
    Rev Prat; 2002 Mar; 52(6):679-82. PubMed ID: 12001420
    [No Abstract]   [Full Text] [Related]  

  • 12. New cystic fibrosis genetic tests bring hope and dilemmas.
    Arnold C
    Lancet Respir Med; 2014 Jan; 2(1):30. PubMed ID: 24461897
    [No Abstract]   [Full Text] [Related]  

  • 13. A high frequency of the Cystic Fibrosis 2184insA mutation in Western Ukraine: genotype-phenotype correlations, relevance for newborn screening and genetic testing.
    Makukh H; Krenková P; Tyrkus M; Bober L; Hancárová M; Hnateyko O; Macek M
    J Cyst Fibros; 2010 Sep; 9(5):371-5. PubMed ID: 20659818
    [TBL] [Abstract][Full Text] [Related]  

  • 14. First report of cystic fibrosis mutations in Libyan cystic fibrosis patients.
    Hadj Fredj S; Fattoum S; Chabchoub A; Messaoud T
    Ann Hum Biol; 2011 Sep; 38(5):561-3. PubMed ID: 21329479
    [TBL] [Abstract][Full Text] [Related]  

  • 15. CF or not CF? That is the question.
    Dodge JA; Dequeker E
    J Cyst Fibros; 2002 Mar; 1(1):3-4. PubMed ID: 15463804
    [No Abstract]   [Full Text] [Related]  

  • 16. End-organ dysfunction in cystic fibrosis: association with angiotensin I converting enzyme and cytokine gene polymorphisms.
    Arkwright PD; Pravica V; Geraghty PJ; Super M; Webb AK; Schwarz M; Hutchinson IV
    Am J Respir Crit Care Med; 2003 Feb; 167(3):384-9. PubMed ID: 12554626
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Mutational spectrum of cystic fibrosis in the Lebanese population.
    Farra C; Menassa R; Awwad J; Morel Y; Salameh P; Yazbeck N; Majdalani M; Wakim R; Yunis K; Mroueh S; Cabet F
    J Cyst Fibros; 2010 Dec; 9(6):406-10. PubMed ID: 20797923
    [TBL] [Abstract][Full Text] [Related]  

  • 18. False negative cystic fibrosis newborn screen.
    Collaco JM; Panny SR; Hamosh A; Mogayzel PJ
    Clin Pediatr (Phila); 2010 Mar; 49(3):214-6. PubMed ID: 20164071
    [No Abstract]   [Full Text] [Related]  

  • 19. CFTR gene analysis in cystic fibrosis patients: detection of 91% of molecular defects and identification of the novel mutation D979V.
    Plouvier E; Cougoureux E; Sardet A; Tournier G; Aymard P; Feldmann D
    Ann Genet; 1997; 40(3):185-8. PubMed ID: 9401110
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Serum-angiotensin-converting-enzyme in chronic granulomatous disease.
    Romer FK; Faber V; Koch C; Pedersen FK; Friis B; Johansen KS; Taudorff E
    Lancet; 1979 Jun; 1(8128):1237. PubMed ID: 87695
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 5.